0001558370-22-013353 Sample Contracts

CREDIT AGREEMENT AND GUARANTYdated as of April 19, 2022by and amongBIOXCEL THERAPEUTICS, INC.,as the Borrower,THE SUBSIDIARY GUARANTORS FROM TIME TO TIME PARTY HERETO,as the Guarantors,THE LENDERS FROM TIME TO TIME PARTY HERETOas the Lenders,...

Credit Agreement and Guaranty • August 11th, 2022 • BioXcel Therapeutics, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Credit Agreement and Guaranty
• Filed
  August 11th, 2022
• Company
  BioXcel Therapeutics, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

REVENUE INTEREST FINANCING AGREEMENT Dated as of April 19, 2022 between BIOXCEL THERAPEUTICS, INC., THE PURCHASERS FROM TIME TO TIME PARTY HERETO, and OAKTREE FUND ADMINISTRATION, LLC, as the Administrative Agent

Revenue Interest Financing Agreement • August 11th, 2022 • BioXcel Therapeutics, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Revenue Interest Financing Agreement
• Filed
  August 11th, 2022
• Company
  BioXcel Therapeutics, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This REVENUE INTEREST FINANCING AGREEMENT (as amended, supplemented or otherwise modified from time to time, this “Agreement”) is made and entered into as of April 19, 2022, by and between BioXcel Therapeutics, Inc., a Delaware corporation (the “Company”), the entities listed in Schedule 1 hereto (the “Purchasers”), and Oaktree Fund Administration, LLC, as administrative agent for the Purchasers (in such capacity, the “Administrative Agent” and, together with the Company and the Purchasers, the “Parties”, and each a “Party”).

Certain information marked as [***] has been excluded from this exhibit because it is both (i) not material and (ii) of the type that the registrant customarily and actually treats as confidential. COMMERCIAL SUPPLY AGREEMENT By and Between ARx, LLC...

Commercial Supply Agreement • August 11th, 2022 • BioXcel Therapeutics, Inc. • Pharmaceutical preparations • Delaware

• Contract Type
  Commercial Supply Agreement
• Filed
  August 11th, 2022
• Company
  BioXcel Therapeutics, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

This Commercial Supply Agreement (this “Agreement”), dated as of April 1, 2022 (the “Effective Date”) is entered into by and between, BioXcel Therapeutics, Inc., a Delaware corporation, with an address at 555 Long Wharf Drive, 5th Floor, New Haven, CT 06511 USA (“BioXcel”), and ARx, LLC, a Pennsylvania limited liability company, with an address at 400 Seaks Run Road, Glen Rock, PA 17327 (“ARx” and together with BioXcel, each a “Party” and collectively, the “Parties”).